Beijing SUCCEEDER na faavaeina i le 2003, faʻapitoa faʻapitoa i le suʻesuʻeina o le toto toto, faʻamalosi faʻamalosi, suʻesuʻega ESR ma isi.
I le avea ai o se tasi o taʻutaʻua taʻutaʻua i Saina Suʻesuʻega maketi o Thrombosis ma Hemostasis, SUCCEEDER ua i ai le poto masani 'au o le R&D, Gaosiga, Faʻatauga Faʻatau ma Auaunaga Tuʻuina atu suʻesuʻega faʻamalosi ma reagents, suʻesuʻega toto toto, suʻesuʻega ESR ma HCT, suʻesuʻega faʻapipiʻi platelet ma ISO13485,CE tusipasi ma le lisi FDA.
SF-8100 o le fuaina lea o le malosi o le tagata ma'i e fai ma fa'amuta fa'atupu toto.Le faia o mea su'ega eseese.SF-8100 ei ai 2 metotia su'ega (fa'ainisinia ma opitika faiga fua) i totonu e iloa ai 3 au'ili'ili metotia o le clotting auala, chromogenic substrate metotia ma immunoturbidimetric metotia.
SF-8100 integrates le cuvettes faiga fafaga, Incubation ma fua faiga, faiga pulea vevela, faiga faamamaina, faiga fesootaiga ma polokalama polokalama e ausia ai se savali atoatoa le faiga suega otometi.
O iunite taʻitasi o le SF-8100 ua maeʻa siaki ma faʻataʻitaʻiina e tusa ai ma tulaga faʻavaomalo faʻavaomalo, alamanuia ma atinaʻe ina ia avea ma oloa maualuga.
Lalo o le SF-8100 auiliiliga ata:
Kata pisinisi
Saina WeChat
Igilisi WeChat